Correlation Between Travere Therapeutics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Viridian Therapeutics, you can compare the effects of market volatilities on Travere Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Viridian Therapeutics.
Diversification Opportunities for Travere Therapeutics and Viridian Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Travere and Viridian is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Viridian Therapeutics
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.89 times more return on investment than Viridian Therapeutics. However, Travere Therapeutics is 1.12 times less risky than Viridian Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,788 in Travere Therapeutics on August 29, 2024 and sell it today you would earn a total of 118.00 from holding Travere Therapeutics or generate 6.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Viridian Therapeutics
Performance |
| Timeline |
| Travere Therapeutics |
| Viridian Therapeutics |
Travere Therapeutics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Viridian Therapeutics
The main advantage of trading using opposite Travere Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |